Patient
P2B-129
completed Phase IIA Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Lviv State Oncological Regional Treatment - Diagnostics Center, Chemotherapy Department (Lviv, Ukraine) (Dr. Okafor)
consented 2013-07-08
Adverse events
8
Serious AEs
2
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 8
Grade 3 anaemia with onset in cycle 5 (2013-10-30); serious (hospitalization); assessed as related to study drug (probable); resolved 2013-12-02; action: drug interrupted.
Grade 2 anaemia with onset in cycle 4 (2013-10-12); assessed as related to study drug (probable); resolved 2013-11-13.
Grade 1 stomatitis with onset in cycle 4 (2013-10-03); assessed as related to study drug (probable); resolved 2013-10-09.
Grade 2 asthenia with onset in cycle 4 (2013-10-02); assessed as not related to study drug (unlikely); resolved 2013-10-29.
Grade 1 thrombocytopenia with onset in cycle 3 (2013-09-17); assessed as related to study drug (probable); resolved 2013-09-27.
Grade 2 alopecia with onset in cycle 1 (2013-08-17); assessed as related to study drug (probable); not resolved at last follow-up.
Grade 2 pain in extremity with onset in cycle 1 (2013-08-13); assessed as not related to study drug (unlikely); resolved 2013-08-26.
Grade 3 thrombocytopenia with onset in cycle 1 (2013-08-06); serious (hospitalization); assessed as related to study drug (probable); resolved 2013-08-17.
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.